Plexus saw no growth in patent filings in April and highest growth of 1.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Plexus’s patent filings and grants. Buy the databook here.
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
Plexus has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The United States(US) patent Office are among the top ten patent offices where Plexus is filings its patents. Among the top granted patent authorities, Plexus has 100% of its grants in United States(US).
Johnson & Johnson could be the strongest competitor for Plexus
Patents related to healthtech and connected patient lead Plexus's portfolio
Plexus has the highest number of patents in healthtech followed by, connected patient and remote patient monitoring. For healthtech no patents were filed and 33% of patents were granted in Q2 2024.
General surgery devices related patents lead Plexus portfolio followed by small arms and light weapons, and hospital supplies
Plexus has highest number of patents in general surgery devices followed by small arms and light weapons, hospital supplies, development software, and enterprise applications. For general surgery devices, nearly 50% of patents were filed and 4% of patents were granted in Q2 2024.
For comprehensive analysis of Plexus's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

